Seribantumab (Anti-ERBB3 / HER3)
Seribantumab (Anti-ERBB3 / HER3) is a fully human IgG2 monoclonal antibody that targets HER3. It inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models. MW : 143.14 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2660 |
| Sku # | A2660-1mg*25 |
| Pricing | 1mg*25, $2370.00 |